Horan Capital Management Has Lifted Bristol (BMY) Position; Western Asset Premier Bond Fund (WEA)’s Sentiment Is 0.93

Horan Capital Management increased Bristol (BMY) stake by 2.09% reported in 2017Q3 SEC filing. Horan Capital Management acquired 5,075 shares as Bristol (BMY)’s stock declined 1.04%. The Horan Capital Management holds 247,956 shares with $15.80M value, up from 242,881 last quarter. Bristol now has $99.77 billion valuation. The stock decreased 0.88% or $0.54 during the last trading session, reaching $60.96. About 5.48M shares traded or 2.50% up from the average. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since December 25, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

The stock increased 0.22% or $0.03 during the last trading session, reaching $13.56. About 25,423 shares traded. Western Asset Premier Bond Fund (WEA) has risen 7.24% since December 25, 2016 and is uptrending. It has underperformed by 9.46% the S&P500.

Robinson Capital Management Llc holds 1.11% of its portfolio in Western Asset Premier Bond Fund for 178,499 shares. Provise Management Group Llc owns 204,094 shares or 0.41% of their US portfolio. Moreover, Koshinski Asset Management Inc. has 0.25% invested in the company for 55,850 shares. The Minnesota-based Sit Investment Associates Inc has invested 0.14% in the stock. 1607 Capital Partners Llc, a Virginia-based fund reported 54,087 shares.

Since September 6, 2017, it had 1 insider buy, and 2 insider sales for $646,385 activity. Lynch Thomas J. Jr. had sold 5,300 shares worth $335,172. Another trade for 9,340 shares valued at $560,400 was sold by Caldarella Joseph C. Samuels Theodore R. II also bought $249,187 worth of Bristol-Myers Squibb Company (NYSE:BMY) shares.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company has $80 highest and $45 lowest target. $62.53’s average target is 2.58% above currents $60.96 stock price. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. Jefferies maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Wednesday, August 23. Jefferies has “Buy” rating and $66.0 target. The firm earned “Hold” rating on Monday, October 16 by SunTrust. The rating was maintained by Leerink Swann on Monday, October 23 with “Outperform”. On Thursday, August 27 the stock rating was maintained by Jefferies with “Hold”. Citigroup maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Wednesday, October 25. Citigroup has “Buy” rating and $72.0 target. Barclays Capital maintained Bristol-Myers Squibb Company (NYSE:BMY) on Friday, October 13 with “Equal-Weight” rating. The rating was maintained by Barclays Capital with “Equal Weight” on Friday, April 29. The company was maintained on Wednesday, August 16 by BMO Capital Markets. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by Berenberg on Friday, January 22. On Tuesday, September 29 the stock rating was upgraded by UBS to “Buy”.